FDA Adverse Event Injury Summary report: N

SPACEOAR VUE SYSTEM

MDR report key: 11912284 · Received June 1, 2021

Report

Report Number
3005099803-2021-02457
Event Type
Injury
Date Received
June 1, 2021
Date of Event
February 1, 2021
Report Date
June 1, 2021
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
OVB
PMA / PMN Number
K182971
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE EXACT DATE OF THE EVENT IS UNKNOWN. THE PROVIDED EVENT DATE, (B)(6) 2021, WAS CHOSEN AS A BEST ESTIMATE BASED ON THE DATE THAT THE MANUFACTURER BECAME AWARE OF THE EVENT, 24FEB2021. THE COMPLAINANT WAS UNABLE TO PROVIDE THE SUSPECT DEVICE LOT NUMBER. THEREFORE, THE EXPIRATION AND DEVICE MANUFACTURE DATES ARE UNKNOWN. (B)(4). THE COMPLAINANT INDICATED THAT THE DEVICE REMAINS IMPLANTED AND WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MDR WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT SPACEOAR VUE WAS IMPLANTED DURING A SPACEOAR VUE PLACEMENT PROCEDURE PERFORMED ON (B)(6) 2021. THE PATIENT DEVELOPED URINARY RETENTION ISSUES SEVERAL DAYS AFTER THE PROCEDURE. THE PHYSICIAN CONFIRMED THAT THE GEL WAS IN THE CORRECT PLACE AND THE MARKERS WERE IN CORRECT LOCATION. THE PATIENT WAS THEN SCOPED TO ENSURE THERE WERE NO BLOCKAGES IN THE URETHRA, AND FOUND NONE. THE PATIENT HAS ALSO BEEN SUFFERING FROM BENIGN PROSTATIC HYPERPLASIA (BPH) ISSUES. THE PATIENT WAS PRESCRIBED WITH SELF-CATHERIZATION. ON (B)(6) 2021, THE PATIENT COMPLETED HIS RADIATION THERAPY. PATIENT ALSO DEVELOPED AN INFECTION, A BIG RETRO PROSTATIC ABSCESS, SEPTIC POST RADIATION, AND WAS HOSPITALIZED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
809623 SPACEOAR VUE SYSTEM ABSORBABLE PERIRECTAL SPACER OVB BOSTON SCIENTIFIC CORPORATION SV-2101

Patients

Seq Age Sex Outcome Treatment
1 Other